Showing results (2051-2060 of 2,230) with videos related to

Sort By:
Pageof 223
Diabetology & Metabolic Syndrome|March 11, 2014
Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE)Tomoya Mita, Naoto Katakami, Toshihiko Shiraiwa, et al.
Lung Cancer (Amsterdam, Netherlands)|May 17, 2005
Cytological characteristics of pulmonary large cell neuroendocrine carcinomaKenzo Hiroshima, Shosaku Abe, Yoshiro Ebihara, et al.
Thrombosis Research|October 29, 2008
Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosisToshiyuki Miyata, Yukiko Sato, Junko Ishikawa, et al.
Cancer Epidemiology|August 29, 2014
Significant association between hypolipoproteinemia(a) and lifetime risk of cancer: an autopsy study from a community-based Geriatric HospitalMakiko Naka Mieno, Motoji Sawabe, Noriko Tanaka, et al.
Cancer Science|February 9, 2018
Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cellsMitsuo Nishiyama, Ryouichi Tsunedomi, Kiyoshi Yoshimura, et al.
Breast Cancer (Tokyo, Japan)|April 26, 2017
A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancerShigeru Yamamoto, Noriko Maeda, Yukiko Nagashima, et al.
Vaccines|September 23, 2022
Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan?Asami Yagi, Yutaka Ueda, Satoshi Nakagawa, et al.
Biochemistry and Biophysics Reports|March 7, 2022
TGF-β1 increases cellular invasion of colorectal neuroendocrine carcinoma cell line through partial epithelial-mesenchymal transitionNorihiko Sasaki, Seiichi Shinji, Yuuki Shichi, et al.
Oncology Reports|November 24, 2016
MicroRNA-6826 and -6875 in plasma are valuable non‑invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancerTaiki Kijima, Shoichi Hazama, Ryouichi Tsunedomi, et al.
BMC Cancer|May 4, 2012
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease courseDaiki Ueno, Masahiro Yao, Ukihide Tateishi, et al.
Pageof 223